BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Alterome Therapeutics, Inc.
Verastem, Inc.
Astellas Pharma Inc
Tizona Therapeutics, Inc
University of Chicago
AVEO Pharmaceuticals, Inc.
Eye & ENT Hospital of Fudan University